As previously reported, the downregulation of RUNX2 by ActRIIA during the early stages of CKD contributes to the development of osteoporosis components of MBD and cardiovascular diseases (Williams et al. 2018). The gene discussed is ACVR2A; the disease is cardiovascular disorder.